Evidence map›Paper›PMID 33275606›Full record

ArticlePLoS computational biology2020

The DIOS framework for optimizing infectious disease surveillance: Numerical methods for simulation and multi-objective optimization of surveillance network architectures.

Qu Cheng, Philip A Collender, Alexandra K Heaney, Xintong Li, Rohini Dasan, Charles Li, Joseph A Lewnard, Jonathan L Zelner, Song Liang, Howard H Chang and 4 more

Abstract read
In one paragraph

Article in PLoS computational biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Qu ChengDivision of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America.ORCID 0000-0003-3074-9218
Philip A CollenderDivision of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America.ORCID 0000-0003-1130-7123
Alexandra K HeaneyDivision of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America.
Xintong LiDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0001-5961-2085
Rohini DasanDivision of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America.ORCID 0000-0002-9215-1628
Charles LiDivision of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America.ORCID 0000-0001-7088-6087
Joseph A LewnardDivision of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America.ORCID 0000-0002-5417-8475
Jonathan L ZelnerDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, United States of America.
Song LiangDepartment of Environmental and Global Health, College of Public Health and Health Professions, and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.
Howard H ChangDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
Lance A WallerDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0001-5002-8886
Benjamin A LopmanDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0002-9238-0068
Changhong YangInstitute of Health Informatics, Sichuan Center for Disease Control and Prevention, Chengdu, Sichuan, People's Republic of China.
Justin V RemaisDivision of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, United States of America.

Funding

Integrating Epidemiologic and Environmental Approaches to Understand and Predict Coccidioides Exposure and Coccidioidomycosis EmergenceR01AI148336 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI REMAIS, JUSTIN V · 2020 to 2024
$4.5M
Spatio-temporal data integration methods for infectious disease surveillanceR01AI125842 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHANG, HOWARD H, REMAIS, JUSTIN V · 2017 to 2021
$3.6M
Effects of agricultural expansion and intensification on infectionsR01TW010286 · FIC · UNIVERSITY OF SOUTH FLORIDA · PI REMAIS, JUSTIN V, ROHR, JASON ROBERT · 2015 to 2019
$2.4M
FIC NIH HHS R01 TW010286NIAID NIH HHS R01 AI125842NIAID NIH HHS R01 AI148336
6 · The paper itself

Abstract

Infectious disease surveillance systems provide vital data for guiding disease prevention and control policies, yet the formalization of methods to optimize surveillance networks has largely been overlooked. Decisions surrounding surveillance design parameters-such as the number and placement of surveillance sites, target populations, and case definitions-are often determined by expert opinion or deference to operational considerations, without formal analysis of the influence of design parameters on surveillance objectives. Here we propose a simulation framework to guide evidence-based surveillance network design to better achieve specific surveillance goals with limited resources. We define evidence-based surveillance design as an optimization problem, acknowledging the many operational constraints under which surveillance systems operate, the many dimensions of surveillance system design, the multiple and competing goals of surveillance, and the complex and dynamic nature of disease systems. We describe an analytical framework-the Disease Surveillance Informatics Optimization and Simulation (DIOS) framework-for the identification of optimal surveillance designs through mathematical representations of disease and surveillance processes, definition of objective functions, and numerical optimization. We then apply the framework to the problem of selecting candidate sites to expand an existing surveillance network under alternative objectives of: (1) improving spatial prediction of disease prevalence at unmonitored sites; or (2) estimating the observed effect of a risk factor on disease. Results of this demonstration illustrate how optimal designs are sensitive to both surveillance goals and the underlying spatial pattern of the target disease. The findings affirm the value of designing surveillance systems through quantitative and adaptive analysis of network characteristics and performance. The framework can be applied to the design of surveillance systems tailored to setting-specific disease transmission dynamics and surveillance needs, and can yield improved understanding of tradeoffs between network architectures.

Indexed as

Computer SimulationData Interpretation, StatisticalCommunicable DiseasesHumansPopulation Surveillance

Identifiers

PMID33275606
PMCPMC7744064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.